Actually, trends in the alteration of these downstream proteins were consistent with the results reported by Chen et al. They demonstrated that TRPM2-S could promote neuroblastoma cell proliferation by activating ERK, Akt, and increasing the level of Glut1 [20]. The gene discussed is SLC2A1; the disease is neuroblastoma.